Fuji Pharma: Change Report
Fuji Pharma: Announcements of individual stocks regarding the determination of matters related to stock acquisition in the stock compensation system.
Fuji Pharma: Announcements of individual stocks regarding the disposal of treasury stock through third-party allotment due to the continuation of the stock compensation system.
Fuji Pharma: Short message for the third quarter financial results (consolidated) for the period of September 2024 [Japanese standard]
Fuji Pharma: Announcements of subscription rights for the issuance of first to third series by third-party allocation.
Fuji Pharma: Securities registration form (reference method)
Fuji Pharma: Announcement of changes in the representative director.
Fuji Pharma: Quarterly Report - 60th Quarter 2 (2024/01/01 to 2024/03/31)
Fuji Pharma: Confirmation letter
Fuji Pharma: Notice regarding differences between second-quarter earnings forecasts and actual results and partial revisions to full-year earnings forecasts
Fuji Pharma: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending 2024/9 [Japanese GAAP] (Consolidated)
Fuji Pharma: Change Report
Fuji Pharmaceutical Industries: Confirmation
Fuji Pharmaceutical Industries: Quarterly Report - First quarter of the 60th term (2023/10/01 - 2023/12/31)
Fuji Pharma: Summary of Financial Results for the 1st Quarter Ending 2024/9 [Japanese GAAP] (Consolidated)
Fuji Pharma: Succession of manufacturing and sales approval for 3 products from Mitsubishi Tanabe Pharma to Fuji Pharmaceutical
Fuji Pharma: Report on Corporate Governance 2023/12/21
Fuji Pharma: Extraordinary Report
Fuji Pharma: Confirmation letter
Fuji Pharma: Internal Control Report - Period 59 (2022/10/01 - 2023/09/30)
No Data